fbpx

AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation By Medicare

A federal judge disagreed with AstraZeneca’s claims that the Inflation Reduction Act causes harm by disincentivizing innovation and violates its constitutional rights to due process. Blockbuster AstraZeneca drug Farxiga is one of 10 medications selected for the Medicare drug price negotiation program created by the law.

The post AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation By Medicare appeared first on Above the Law.

Related Articles

Responses

Your email address will not be published. Required fields are marked *